Jessica Mendoza

Still, Vitro's argument is resonating among China hawks in Washington.

There's a related national security concern as well, especially as tensions between the US and China ratchet up.

Are we seeing this in other industries currently or beyond just sort of Fuyao and Vitro?

So it sounds like there's a bit of tension in Trump's trade policy here.

He wants countries to make their stuff here in the U.S., but then there's also concern about them controlling the market with low prices.

A White House spokesman said that the administration is committed to securing more investment in American manufacturing without compromising on national and economic security.

For Vitro and its plant in Crestline, Ohio, the long-term future is still uncertain.

Vitro executives announced that the plant would remain open through the year, but the company is still struggling to compete.

Meanwhile, Fuyao has continued to expand.

What is the lesson here?

What is it showing about the risks to inviting foreign manufacturing, specifically Chinese manufacturing, into the U.S.

?

That's all for today, Tuesday, February 24th.

The Journal is a co-production of Spotify and The Wall Street Journal.

If you like our show, follow us on Spotify or wherever you get your podcasts.

We're out every weekday afternoon.

Thanks for listening.

See you tomorrow.

Top names in the U.S.

defense industry got together last week for a meeting in West Palm Beach.